Cite
HARVARD Citation
Patterson, B. et al. (2021). CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14. International journal of infectious diseases. pp. 25-32. [Online].